Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials

耐受性 曲唑酮 安慰剂 医学 随机对照试验 原发性失眠 内科学 置信区间 失眠症 麻醉 不利影响 睡眠障碍 精神科 抗抑郁药 替代医学 海马体 病理
作者
Xiaoyan Yi,Shifen Ni,Mohammad Rasoul Ghadami,Huaqing Meng,Mingyan Chen,Li Kuang,Yuqing Zhang,Li Zhang,Xinyu Zhou
出处
期刊:Sleep Medicine [Elsevier BV]
卷期号:45: 25-32 被引量:79
标识
DOI:10.1016/j.sleep.2018.01.010
摘要

To assess the efficacy and tolerability of trazodone compared with placebo in patients with insomnia. Electronic databases were searched and relevant reports were hand-screened to identify eligible trials. Only randomized placebo-controlled trials were included. Standardized mean differences (SMD) and the odds ratios (OR) were estimated using a random-effect model. Primary efficacy outcomes included sleep efficiency (SE%) and self-reported sleep quality (SQ). Secondary efficacy outcomes included sleep latency (SL), total sleep time (TST), the number of awakenings (NAs), waking time after sleep onset (WASO). Tolerability outcome was measured by the number of patients who discontinued for adverse events and acceptability outcome was measured by the number of patients who discontinued for all causes. Seven trials involving 429 patients were included. There was no significant improvement for trazodone in SE% (SMD = 0.09, 95% confidence interval (CI) −0.19 to 0.38, P = 0.53) with a non-significant heterogeneity (I2 = 0%, P = 0.59). However, patients receiving trazodone perceived better SQ than those receiving the placebo (SMD = −0.41, 95% CI −0.82 to −0.00, P = 0.05) with a non-significantly moderate heterogeneity (I2 = 65%, P = 0.06). As to secondary efficacy outcomes, we only found a significant reduction for trazodone in NAs (SMD = −0.51, 95%CI −0.97 to −0.05) compared to the placebo, with non-significant differences found in SL, TST, or WASO between trazodone and placebo. Moreover, no significant difference was found in the outcome of tolerability or acceptability. Trazodone was effective in sleep maintenance by decreasing the number of early awakenings and it could significantly improve perceived sleep quality, although there were no significant improvements in sleep efficiency or other objective measures. Trazodone however, presented good tolerance in the short-term treatment of insomnia.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Wendy完成签到,获得积分10
刚刚
qin202569发布了新的文献求助10
刚刚
1秒前
kita发布了新的文献求助10
2秒前
2秒前
3秒前
5秒前
5秒前
我哪知道怎么完成签到 ,获得积分10
6秒前
liputao完成签到 ,获得积分10
6秒前
6秒前
现代的bb发布了新的文献求助10
6秒前
AKira完成签到 ,获得积分10
7秒前
空集发布了新的文献求助10
7秒前
yi完成签到,获得积分0
8秒前
田様的应助被明亮的迎松采纳,获得10
8秒前
风吹麦浪的应助被清脆香露采纳,获得10
8秒前
一二三发布了新的文献求助10
8秒前
slowww完成签到 ,获得积分10
9秒前
YZF关注了科研通微信公众号
9秒前
10秒前
wand枘发布了新的文献求助10
10秒前
万能图书馆的应助被moonlamb采纳,获得10
10秒前
深情安青的应助被yjt采纳,获得10
11秒前
13秒前
大模型的应助被尊敬谷波采纳,获得20
13秒前
14秒前
15秒前
15秒前
16秒前
16秒前
369ninja发布了新的文献求助10
16秒前
18秒前
赘婿的应助被坦率紫烟采纳,获得10
18秒前
秋风的应助被明亮的迎松采纳,获得10
18秒前
18秒前
丘比特的应助被空集采纳,获得10
18秒前
19秒前
nn发布了新的文献求助10
19秒前
鑫鑫发布了新的文献求助10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184240
求助须知:如何正确求助?哪些是违规求助? 9573297
关于积分的说明 21830585
捐赠科研通 7781300
什么是DOI,文献DOI怎么找? 3434285
关于科研通互助平台的介绍 2558389
邀请新用户注册赠送积分活动 2480814